Soins de support LE DECLIC-EPRI (IC 2019-06) DECLIC Patient Education Program : Assessment Through a Population Health Intervention Research Approach (LE DECLIC EPRI. Paris, Saint-Cloud EVELYNE RENAULT TESSIER
Appareil Digestif PERSPECTIVE (MS202202-0002) A Phase II Single-Arm Study to Investigate Tepotinib Combined With Cetuximab in RAS/BRAF Wild-Type Left-Sided mCRC Patients Having Acquired Resistance to Anti-EGFR Antibody Targeting Therapy Due to MET Amplification (PERSPECTIVE) Saint-Cloud
Appareil pulmonaire RADIO-RYTHMIC-01 (IC 2020-09) Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma Paris NICOLAS GIRARD
Appareil pulmonaire CA224-104 (RELATIVITY) A Phase 2 Randomized Double-blind Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) Paris NICOLAS GIRARD
Appareil pulmonaire ELDERLY Phase III randomized trial of atezolizumab in elderly patients with advanced Non-Small-Cell Lung Cancer and receiving monthly carboplatin with weekly paclitaxel chemotherapy Paris, Saint-Cloud MARIE ANGE MASSIANI, MARIE ANGE MASSIANI
Soins de support ES4-UIC (IC 2020-18) Prospective, Observational Study Evaluating the Feasibility of a Systematic and Standardized Assessment of Supportive Care Needs in Patients With Advanced Solid Cancer at the Inclusion in a Therapeutic Trial at the Institut Curie Paris PAULINE DU RUSQUEC
Gynécologie - Ovaires MIRASOL MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression. Saint-Cloud
Appareil pulmonaire LIST CA209-7HX A Multi-Center, Longitudinal, Prospective, Observational, Multi-Cohort Study of Patients;with Advanced Non-Small Cell Lung Cancer treated with nivolumab in France after at least;one prior chemotherapy-based treatment (LIST, Lung Initiative on Sequence Therapy) Paris CATHERINE DANIEL